Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)

Induced pluripotent stem cells (iPSCs) hold great promise as a potential source for regenerative medicine. Umbilical cord blood (UCB) cells possess a high level of stem cells, exhibit less immune rejection, and have fewer DNA mutations and, thus, are an easily accessible and valuable cell source for...

Full description

Bibliographic Details
Main Authors: Hyebin Koh, Xing Zhen, Jieun Kim, Hye-Yeong Ha, Jong-Hee Lee
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S187350612200023X
_version_ 1818287628265455616
author Hyebin Koh
Xing Zhen
Jieun Kim
Hye-Yeong Ha
Jong-Hee Lee
author_facet Hyebin Koh
Xing Zhen
Jieun Kim
Hye-Yeong Ha
Jong-Hee Lee
author_sort Hyebin Koh
collection DOAJ
description Induced pluripotent stem cells (iPSCs) hold great promise as a potential source for regenerative medicine. Umbilical cord blood (UCB) cells possess a high level of stem cells, exhibit less immune rejection, and have fewer DNA mutations and, thus, are an easily accessible and valuable cell source for iPSC generation for basic research and clinical applications. Here, we reprogrammed CD34+-UCB cells with the group O/D-negative (RhD-) blood type as a universal source for red blood cell (RBC) generation. The resulting iPSCs, with features typical of pluripotent stem cells, will further advance the development of various therapeutics, including blood transfusion.
first_indexed 2024-12-13T01:43:30Z
format Article
id doaj.art-cf71d77773684d08813625c5ec356c11
institution Directory Open Access Journal
issn 1873-5061
language English
last_indexed 2024-12-13T01:43:30Z
publishDate 2022-04-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-cf71d77773684d08813625c5ec356c112022-12-22T00:03:41ZengElsevierStem Cell Research1873-50612022-04-0160102674Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)Hyebin Koh0Xing Zhen1Jieun Kim2Hye-Yeong Ha3Jong-Hee Lee4Futuristic Animal Resource & Research Center (FARRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; Department of Functional Genomics, KRIBB School of Bioscience, University of Science and Technology (UST), Daejeon, Republic of KoreaNational Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; Department of Nanoscience and Nanotechnology, Graduate School, Kyungpook National University, Daegu 41566, Republic of KoreaNational Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaDivision of Intractable Disease Research, Korea National Institute of Health, Cheongju, Republic of KoreaNational Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; Department of Functional Genomics, KRIBB School of Bioscience, University of Science and Technology (UST), Daejeon, Republic of Korea; Corresponding author.Induced pluripotent stem cells (iPSCs) hold great promise as a potential source for regenerative medicine. Umbilical cord blood (UCB) cells possess a high level of stem cells, exhibit less immune rejection, and have fewer DNA mutations and, thus, are an easily accessible and valuable cell source for iPSC generation for basic research and clinical applications. Here, we reprogrammed CD34+-UCB cells with the group O/D-negative (RhD-) blood type as a universal source for red blood cell (RBC) generation. The resulting iPSCs, with features typical of pluripotent stem cells, will further advance the development of various therapeutics, including blood transfusion.http://www.sciencedirect.com/science/article/pii/S187350612200023X
spellingShingle Hyebin Koh
Xing Zhen
Jieun Kim
Hye-Yeong Ha
Jong-Hee Lee
Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)
Stem Cell Research
title Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)
title_full Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)
title_fullStr Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)
title_full_unstemmed Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)
title_short Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A)
title_sort generation and characterization of human umbilical cord blood derived induced pluripotent stem cells kribbi005 a
url http://www.sciencedirect.com/science/article/pii/S187350612200023X
work_keys_str_mv AT hyebinkoh generationandcharacterizationofhumanumbilicalcordbloodderivedinducedpluripotentstemcellskribbi005a
AT xingzhen generationandcharacterizationofhumanumbilicalcordbloodderivedinducedpluripotentstemcellskribbi005a
AT jieunkim generationandcharacterizationofhumanumbilicalcordbloodderivedinducedpluripotentstemcellskribbi005a
AT hyeyeongha generationandcharacterizationofhumanumbilicalcordbloodderivedinducedpluripotentstemcellskribbi005a
AT jongheelee generationandcharacterizationofhumanumbilicalcordbloodderivedinducedpluripotentstemcellskribbi005a